The Biomedical Advanced Research and Development Authority (BARDA), has selected the Coulter Translational Program (now known as Biolocity) to join their network to accelerate the development of technologies to address 21st century health security threats to the United States. The Coulter Program is a philanthropic, multi-institutional network that provides early-stage, patient-impacting university technologies with resources needed to reach commercial success.
BARDA’s 2019 expansion of the Division of Research, Innovation, and Ventures (DRIVe) supports their goal to stimulate investment and innovation in health security products and technologies. The Coulter Program’s role in this network is to identify technologies and companies of strategic interest to DRIVe and bridge the development gap to commercial application by connecting these technologies with BARDA and Coulter resources.
As a member of the DRIVe accelerator network, the Coulter Program will provide innovators and researchers with a key link to BARDA, and other accelerators for funding and resources to support their commercialization. The network will empower entrepreneurs creating medical technologies and create a pipeline of promising health security products.
“Joining this elite, nationwide consortium of DRIVe accelerators is an exciting endorsement for our program,” said Shawna Khouri, Managing Director of the Coulter Program. “We encourage faculty at all Georgia institutions and local start-ups with health security technologies to reach out to us.”
Current areas of focus include solving sepsis, solutions for early notification to act, control, and treat illness, and other disruptive innovations to change the paradigm of health security technologies and approaches.
The expansion of accelerator services was supported by BARDA DRIVe, part of the Assistant Secretary for Preparedness and Response (ASPR), within the United States Department of Health and Human Services(HHS) under award number IDSEP190055.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response.